Verastem Share Price

Verastem Share Price

NASDAQ: VSTM | Small Cap | Healthcare
$6.34
-$0.53 (-7.71%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Verastem Stock Performance

Open
$6.69
Prev. Close
$6.87
Circuit Range
N/A
Day Range
$6.26 - $6.80
Year Range
$3.43 - $10.82
Volume
1,63,673
Average Traded
$6.50

Verastem Share Price Today

As of 22 November 2026, Verastem, Inc.'s share price is $6.34. The stock opened at $6.69, compared to its previous close of $6.87. During today's trading session, Verastem, Inc.'s share price traded between $6.26 and $6.80, with an average price of $6.53. Over the past 52 weeks, the stock has recorded a high of $10.82 and a low of $3.43. In terms of performance, Verastem, Inc.'s share price has risen by 46.59% over the last six months and is down 40.53% on a year-on-year basis.

Verastem Share Price Chart

Line chart of the Verastem price trend over the selected period. The price fell overall, ranging from 6.26 to 6.80, ending at 6.33.
$6.26$6.80
L
Show Current Price
H

Verastem Stock Fundamentals & Key Indicators

Market Cap
$439.42M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.42
Revenue (TTM)
$30.91B
Return On Equity (TTM)
-1771.14%
Profit Margin
-677.68%
Debt to Equity
12.46
Quarterly Earnings Growth YoY
-126.97%

Verastem Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$17.54$18.67$40.08$24.01
Net Profit-$32.92-$36.59-$34.67-$74.72
Net Profit Margin-187.69%-195.98%-86.50%-311.20%
Income ChangeN/A-11.15%5.25%-115.52%

Verastem Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$2.60$0.00$10.00$30.91
Net Profit-$73.81-$87.37-$130.64-$209.47
Net Profit Margin-2838.85%N/A-1306.40%-677.68%
Income ChangeN/A-18.37%-49.53%-60.34%

Verastem Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets23.036.586.042.18
Current Assets223.4194.96143.6892.87
Total Assets246.44101.54149.7295.05
Non Current Liabilities116.9899.4644.8126.0
Current Liabilities72.2730.9726.3821.66
Total Liabilities189.25130.4371.1947.66
Shareholders' Equity57.2-28.8978.5347.39

Verastem Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-137.51-104.77-86.46-63.67
Investing-9.6259.97-44.4566.19
Financing263.3154.78134.1951.78

Corporate Actions

Split
Ex-date: 01 Jun 2023

About Verastem

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Verastem Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$9.70
$6.32
-35.33%
Oct 2026
$8.04
$9.77
+20.70%
Sep 2026
$7.24
$8.09
+9.62%
Aug 2026
$5.79
$7.38
+27.02%
Jul 2026
$3.88
$5.81
+52.49%
Jun 2026
$4.33
$3.81
-11.91%
May 2026
$5.41
$4.33
-20.64%
Apr 2026
$5.39
$5.45
+2.83%
Mar 2026
$5.67
$5.30
-7.34%
Feb 2026
$6.13
$5.72
-6.23%
Jan 2026
$7.68
$6.10
-20.93%
Dec 2025
$10.40
$7.71
-27.63%

Verastem Share Price FAQs